Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Cancer Letters|July 16, 2003
Ten kilodalton heat shock protein (HSP10) is overexpressed during carcinogenesis of large bowel and uterine exocervixFrancesco Cappello, Marianna Bellafiore, Sabrina David, et al.
Anticancer Research|June 25, 2003
Immunohistochemical evaluation of PCNA, p53, HSP60, HSP10 and MUC-2 presence and expression in prostate carcinogenesisFrancesco Cappello, Francesca Rappa, Sabrina David, et al.
Brain Circulation|June 4, 2021
Mitochondrial activity of human umbilical cord mesenchymal stem cellsBlaise M Cozene, Eleonora Russo, Rita Anzalone, et al.
Immunology Letters|August 25, 2004
CD1a and antitumour immune responseGiampiero La Rocca, Rita Anzalone, Fabio Bucchieri, et al.
Respiratory Research|March 14, 2007
Cigarette smoke exposure inhibits extracellular MMP-2 (gelatinase A) activity in human lung fibroblastsGiampiero La Rocca, Rita Anzalone, Francesca Magno, et al.
Stem Cell Reviews and Reports|November 18, 2016
Wharton's Jelly Mesenchymal Stromal Cells as a Feeder Layer for the Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells: a ReviewMelania Lo Iacono, Rita Anzalone, Giampiero La Rocca, et al.
Current Stem Cell Research & Therapy|January 16, 2013
Human Wharton's jelly mesenchymal stem cells maintain the expression of key immunomodulatory molecules when subjected to osteogenic, adipogenic and chondrogenic differentiation in vitro: new perspectives for cellular therapyGiampiero La Rocca, Melania Lo Iacono, Tiziana Corsello, et al.
Histology and Histopathology|April 19, 2013
Umbilical cord revisited: from Wharton's jelly myofibroblasts to mesenchymal stem cellsSimona Corrao, Giampiero La Rocca, Melania Lo Iacono, et al.
Current Stem Cell Research & Therapy|January 3, 2013
New frontiers in regenerative medicine in cardiology: the potential of Wharton's jelly mesenchymal stem cellsSimona Corrao, Giampiero La Rocca, Melania Lo Iacono, et al.
Stem Cell Reviews and Reports|October 26, 2010
Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetesRita Anzalone, Melania Lo Iacono, Tiziana Loria, et al.
Pageof 3